Tiziana announces availability of march 14 kol event replay

New york, march 15, 2022 (globe newswire) -- tiziana life sciences (nasdaq: tlsa) (“tiziana” or the “company”), a biotechnology company enabling breakthrough immunotherapies via novel routes of drug delivery, announces the availability of the replay of its march 14 kol event entitled “foralumab clinical update in multiple sclerosis” along with the slides from the presentation in the investor presentations section of its website (https://ir.tizianalifesciences.com/presentation). this morning, zacks also published a research note to follow up on the kol presentations and discussion on the positive clinical data after six months of treatment to a spms patient.
TLSA Ratings Summary
TLSA Quant Ranking